These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 29786660)

  • 1. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
    Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic drugs against cancer: an evolving landscape.
    Di Costanzo A; Del Gaudio N; Migliaccio A; Altucci L
    Arch Toxicol; 2014 Sep; 88(9):1651-68. PubMed ID: 25085708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine natural products as breast cancer resistance protein inhibitors.
    Cherigo L; Lopez D; Martinez-Luis S
    Mar Drugs; 2015 Apr; 13(4):2010-29. PubMed ID: 25854646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proprotein convertase inhibition: Paralyzing the cell's master switches.
    Klein-Szanto AJ; Bassi DE
    Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK signaling pathway-targeted marine compounds in cancer therapy.
    Wei J; Liu R; Hu X; Liang T; Zhou Z; Huang Z
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):3-22. PubMed ID: 33389079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds.
    Fan M; Nath AK; Tang Y; Choi YJ; Debnath T; Choi EJ; Kim EK
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29757237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diflomotecan. Ipsen.
    Osheroff N
    IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
    [No Abstract]   [Full Text] [Related]  

  • 11. Marine anticancer drugs and their relevant targets: a treasure from the ocean.
    Nigam M; Suleria HAR; Farzaei MH; Mishra AP
    Daru; 2019 Jun; 27(1):491-515. PubMed ID: 31165439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sponging off nature for new drug leads.
    Andersen RJ
    Biochem Pharmacol; 2017 Sep; 139():3-14. PubMed ID: 28411115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract]   [Full Text] [Related]  

  • 15. Marine Derived Anticancer Drugs Targeting Microtubule.
    De O; Chatterji BP
    Recent Pat Anticancer Drug Discov; 2017; 12(2):102-127. PubMed ID: 28067173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting transcription factors by small compounds--Current strategies and future implications.
    Hagenbuchner J; Ausserlechner MJ
    Biochem Pharmacol; 2016 May; 107():1-13. PubMed ID: 26686579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule-targeting anticancer agents from marine natural substance.
    Liu Z; Xu P; Wu T; Zeng W
    Anticancer Agents Med Chem; 2014 Mar; 14(3):409-17. PubMed ID: 24533652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-bound enzymes as epigenetic drug targets in cancer.
    Bomsztyk K; Wang Y
    Epigenomics; 2019 Oct; 11(13):1463-1467. PubMed ID: 31536377
    [No Abstract]   [Full Text] [Related]  

  • 19. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.
    Sawadogo WR; Schumacher M; Teiten MH; Cerella C; Dicato M; Diederich M
    Molecules; 2013 Mar; 18(4):3641-73. PubMed ID: 23529027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.